David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRS
3576
DELISTED
Verso Corporation
VRS
| $191K | ﹤0.01% |
16,953
-18,143
| -52% | -$283K |
|
|
BRY
3577
DELISTED
Berry Corp
BRY
| $190K | ﹤0.01% |
78,900
+15,671
| +25% | +$96.2K |
|
3578
PUT
Century Aluminum
CENX
$4.32B
| $190K | ﹤0.01% |
+52,500
| New | +$294K |
|
|
WTRE
3579
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $190K | ﹤0.01% |
12,965
-3,917
| -23% | -$86K |
|
|
BMY.RT
3580
CALL
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $190K | ﹤0.01% |
50,000
-104,200
| -68% | -$343K |
|
3581
PUT
Ethan Allen Interiors
ETD
$592M
| $189K | ﹤0.01% |
+18,500
| New | +$270K |
|
3582
Kosmos Energy
KOS
$1.7B
| $189K | ﹤0.01% |
211,413
-1,492,516
| -88% | -$5.93M |
|
3583
PUT
Antero Midstream
AM
$10.5B
| $188K | ﹤0.01% |
89,600
| – | – |
|
|
FNHC
3584
DELISTED
FedNat Holding Company Common Stock
FNHC
| $188K | ﹤0.01% |
+16,362
| New | +$229K |
|
3585
Wabash National
WNC
$491M
| $187K | ﹤0.01% |
25,900
-256,722
| -91% | -$2.88M |
|
3586
CALL
Matador Resources
MTDR
$7.12B
| $186K | ﹤0.01% |
+75,000
| New | +$824K |
|
|
AWF
3587
AllianceBernstein Global High Income Fund
AWF
$872M
| $185K | ﹤0.01% |
+20,000
| New | +$228K |
|
3588
PUT
B&G Foods
BGS
$284M
| $185K | ﹤0.01% |
10,200
-5,800
| -36% | -$90.8K |
|
|
DHC
3589
Diversified Healthcare Trust
DHC
$1.94B
| $182K | ﹤0.01% |
50,100
-23,447
| -32% | -$154K |
|
3590
CALL
Kohl's
KSS
$2.08B
| $182K | ﹤0.01% |
12,500
-118,800
| -90% | -$4.45M |
|
|
RVNC
3591
DELISTED
Revance Therapeutics, Inc.
RVNC
| $182K | ﹤0.01% |
+12,300
| New | +$254K |
|
|
DCH
3592
CALL
Dauch Corp
DCH
$1.53B
| $181K | ﹤0.01% |
50,000
-4,200
| -8% | -$31.2K |
|
|
HTT
3593
PUT
High Templar Tech Ltd
HTT
$393M
| $180K | ﹤0.01% |
+100,000
| New | +$281K |
|
|
PDCE
3594
DELISTED
PDC Energy, Inc.
PDCE
| $178K | ﹤0.01% |
28,716
+11,405
| +66% | +$205K |
|
3595
NN Inc
NNBR
$301M
| $177K | ﹤0.01% |
102,259
+62,356
| +156% | +$446K |
|
3596
PUT
Olin
OLN
$2B
| $177K | ﹤0.01% |
15,200
-218,500
| -93% | -$3.31M |
|
3597
Construction Partners
ROAD
$6.16B
| $177K | ﹤0.01% |
10,461
-5,277
| -34% | -$87.7K |
|
|
BBBY
3598
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $176K | ﹤0.01% |
41,900
-18,100
| -30% | -$211K |
|
|
AIMT
3599
DELISTED
Aimmune Therapeutics
AIMT
| $176K | ﹤0.01% |
12,200
-19,115
| -61% | -$489K |
|
|
EPZM
3600
DELISTED
Epizyme, Inc
EPZM
| $173K | ﹤0.01% |
11,124
-177,300
| -94% | -$3.81M |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.